Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Longini

Showing results (41-50 of 260) with videos related to

Pageof 26
Sort By:
Biometrics|April 21, 2001
Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: randomization by individual versus householdS Datta, M E Halloran, I M Longini
Statistics in Medicine|February 12, 2002
Model-based estimation of vaccine effects from community vaccine trialsIra M Longini, M Elizabeth Halloran, Azhar Nizam
American Journal of Epidemiology|August 11, 1992
Interpretation and estimation of vaccine efficacy under heterogeneityM E Halloran, M Haber, I M Longini
Journal of Human Hypertension|May 1, 1994
Selenium and hypertension: preliminary dataM Strambi, F Paciotti, M Longini, et al.
Biostatistics (Oxford, England)|February 10, 2009
A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infectionsYang Yang, M Elizabeth Halloran, Ira M Longini
BMJ (Clinical Research Ed.)|September 10, 2009
A/H1N1 flu pandemic. Antiviral drugs: distinguish treatment from prophylaxisBenjamin J Cowling, Sophia Ng, Ira M Longini
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Updated projections for COVID-19 omicron wave in FloridaThomas J Hladish, Alexander N Pillai, Ira M Longini
American Journal of Epidemiology|July 1, 1996
Estimability and interpretation of vaccine efficacy using frailty mixing modelsM E Halloran, I M Longini, C J Struchiner
Statistics in Medicine|November 20, 1998
Semi-parametric models for mismeasured exposure information in vaccine trialsG T Golm, M E Halloran, I M Longini
The Annals of Applied Statistics|April 3, 2018
DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATORNatalie E Dean, M Elizabeth Halloran, Ira M Longini
Pageof 26

Showing results (41-50 of 260) with videos related to

Sort By:
Pageof 26
Biometrics|April 21, 2001
Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: randomization by individual versus householdS Datta, M E Halloran, I M Longini
Statistics in Medicine|February 12, 2002
Model-based estimation of vaccine effects from community vaccine trialsIra M Longini, M Elizabeth Halloran, Azhar Nizam
American Journal of Epidemiology|August 11, 1992
Interpretation and estimation of vaccine efficacy under heterogeneityM E Halloran, M Haber, I M Longini
Journal of Human Hypertension|May 1, 1994
Selenium and hypertension: preliminary dataM Strambi, F Paciotti, M Longini, et al.
Biostatistics (Oxford, England)|February 10, 2009
A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infectionsYang Yang, M Elizabeth Halloran, Ira M Longini
BMJ (Clinical Research Ed.)|September 10, 2009
A/H1N1 flu pandemic. Antiviral drugs: distinguish treatment from prophylaxisBenjamin J Cowling, Sophia Ng, Ira M Longini
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Updated projections for COVID-19 omicron wave in FloridaThomas J Hladish, Alexander N Pillai, Ira M Longini
American Journal of Epidemiology|July 1, 1996
Estimability and interpretation of vaccine efficacy using frailty mixing modelsM E Halloran, I M Longini, C J Struchiner
Statistics in Medicine|November 20, 1998
Semi-parametric models for mismeasured exposure information in vaccine trialsG T Golm, M E Halloran, I M Longini
The Annals of Applied Statistics|April 3, 2018
DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATORNatalie E Dean, M Elizabeth Halloran, Ira M Longini
Pageof 26